A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany
Year of publication: |
2006
|
---|---|
Authors: | Beard, Stephen ; Maciver, Fiona ; Clouth, Johannes ; RĂ¼ther, Eckart |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 7.2006, 3, p. 165-172
|
Publisher: |
Springer |
Subject: | Decision support techniques | Atypical antipsychotics | Schizophrenia | Health care costs |
-
Decision models in the evaluation of psychotropic drugs
Barbui, Corrado, (2006)
-
Heterogeneity in action : the role of passive personalization in comparative effectiveness research
Basu, Anirban, (2014)
-
Fairbank, Alan W., (1987)
- More ...
-
Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
Wolowacz, Sorrel, (2007)
-
Diversity, Polarity, Inclusivity: Finding Balance in Design Leadership
Maciver, Fiona, (2012)
-
Cost-effectiveness of febuxostat in chronic gout
Beard, Stephen, (2014)
- More ...